Evidence map›Paper›PMID 33431674›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer.

Po-Hao Chang, Min-Che Chen, Ya-Ping Tsai, Grace Y T Tan, Pang-Hung Hsu, Yung-Ming Jeng, Yi-Fang Tsai, Muh-Hwa Yang, Wendy W Hwang-Verslues

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Collective migration modes in development, tissue repair and cancer.Nature reviews. Molecular cell biology · 2025
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Po-Hao ChangGenomics Research Center, Academia Sinica, 115 Taipei, Taiwan.
Min-Che ChenAsclepiumm Taiwan Co., Ltd, 25160 New Taipei City, Taiwan.ORCID 0000-0002-6765-2228
Ya-Ping TsaiAsclepiumm Taiwan Co., Ltd, 25160 New Taipei City, Taiwan.
Grace Y T TanGenomics Research Center, Academia Sinica, 115 Taipei, Taiwan.
Pang-Hung HsuDepartment of Bioscience and Biotechnology, National Taiwan Ocean University, 20224 Keelung City, Taiwan.ORCID 0000-0001-6873-6434
Yung-Ming JengDepartment of Pathology, National Taiwan University Hospital, 100 Taipei, Taiwan.
Yi-Fang TsaiDepartment of Surgery, Taipei-Veterans General Hospital, 112 Taipei City, Taiwan.
Muh-Hwa YangInstitute of Clinical Medicine, National Yang-Ming University, 112 Taipei, Taiwan.
Wendy W Hwang-VersluesGenomics Research Center, Academia Sinica, 115 Taipei, Taiwan; wendyhv@gate.sinica.edu.tw.ORCID 0000-0002-0383-1710
Genomics Research Center, Academia Sinica · TWTaipei Veterans General Hospital · TWNational Taiwan Ocean University · TWNational Taiwan University Hospital · TWNational Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastasis is the major cause of cancer death. An increased level of circulating tumor cells (CTCs), metastatic cancer cells that have intravasated into the circulatory system, is particularly associated with colonization of distant organs and poor prognosis. However, the key factors required for tumor cell dissemination and colonization remain elusive. We found that high expression of desmoglein2 (DSG2), a component of desmosome-mediated intercellular adhesion complexes, promoted tumor growth, increased the prevalence of CTC clusters, and facilitated distant organ colonization. The dynamic regulation of DSG2 by hypoxia was key to this process, as down-regulation of DSG2 in hypoxic regions of primary tumors led to elevated epithelial-mesenchymal transition (EMT) gene expression, allowing cells to detach from the primary tumor and undergo intravasation. Subsequent derepression of DSG2 after intravasation and release of hypoxic stress was associated with an increased ability to colonize distant organs. This dynamic regulation of DSG2 was mediated by Hypoxia-Induced Factor1α (HIF1α). In contrast to its more widely observed function to promote expression of hypoxia-inducible genes, HIF1α repressed DSG2 by recruitment of the polycomb repressive complex 2 components, EZH2 and SUZ12, to the DSG2 promoter in hypoxic cells. Consistent with our experimental data, DSG2 expression level correlated with poor prognosis and recurrence risk in breast cancer patients. Together, these results demonstrated the importance of DSG2 expression in metastasis and revealed a mechanism by which hypoxia drives metastasis.

Indexed as

AnimalsBreast NeoplasmsCell Line, TumorDesmoglein 2Enhancer of Zeste Homolog 2 ProteinEpithelial-Mesenchymal TransitionFemaleGene Expression Regulation, NeoplasticHumansHypoxiaHypoxia-Inducible Factor 1, alpha SubunitLymphatic MetastasisMiceMice, SCIDNeoplasm ProteinsNeoplasm Recurrence, LocalDesmoglein 2DSG2 protein, humanEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitNeoplasm ProteinsPolycomb Repressive Complex 2RNA, Small InterferingSUZ12 protein, humanTranscription Factorsbreast cancercirculating tumor cells (CTCs)desmoglein2 (DSG2)HIF1αmetastasis

Identifiers

PMID33431674
PMCPMC7826351
OpenAlexW3118823635

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.